MidWestOne Financial Group Inc. reduced its position in shares of Corteva, Inc. (NYSE:CTVA – Free Report) by 1.5% in the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 14,846 shares of the company’s stock after selling 219 shares during the quarter. MidWestOne Financial Group Inc.’s holdings in Corteva were worth $873,000 as of its most recent filing with the Securities and Exchange Commission.
Other large investors have also modified their holdings of the company. Capital Advisors Ltd. LLC boosted its holdings in Corteva by 44.4% in the 3rd quarter. Capital Advisors Ltd. LLC now owns 566 shares of the company’s stock valued at $33,000 after purchasing an additional 174 shares during the period. Cultivar Capital Inc. bought a new stake in Corteva in the 2nd quarter valued at $34,000. Redwood Wealth Management Group LLC bought a new stake in Corteva in the 2nd quarter valued at $43,000. Triad Wealth Partners LLC bought a new stake in Corteva in the 2nd quarter valued at $45,000. Finally, Chilton Capital Management LLC boosted its holdings in Corteva by 354.7% in the 2nd quarter. Chilton Capital Management LLC now owns 973 shares of the company’s stock valued at $52,000 after purchasing an additional 759 shares during the period. 81.54% of the stock is owned by institutional investors.
Corteva Trading Down 0.5 %
Shares of Corteva stock opened at $59.44 on Wednesday. The company has a quick ratio of 0.96, a current ratio of 1.50 and a debt-to-equity ratio of 0.08. The stock has a market capitalization of $40.85 billion, a P/E ratio of 60.04, a price-to-earnings-growth ratio of 1.93 and a beta of 0.77. Corteva, Inc. has a 12-month low of $44.01 and a 12-month high of $64.20. The company has a 50-day simple moving average of $59.58 and a 200 day simple moving average of $56.15.
Corteva Announces Dividend
Corteva announced that its board has authorized a stock repurchase plan on Tuesday, November 19th that authorizes the company to repurchase $3.00 billion in shares. This repurchase authorization authorizes the company to reacquire up to 7.5% of its stock through open market purchases. Stock repurchase plans are generally a sign that the company’s management believes its stock is undervalued.
Wall Street Analysts Forecast Growth
A number of analysts have weighed in on the stock. Oppenheimer reissued an “outperform” rating and issued a $70.00 price target (up from $69.00) on shares of Corteva in a report on Friday, November 8th. Citigroup initiated coverage on shares of Corteva in a report on Wednesday, October 23rd. They set a “buy” rating and a $68.00 price objective for the company. KeyCorp raised their price objective on shares of Corteva from $66.00 to $69.00 and gave the stock an “overweight” rating in a report on Thursday, November 21st. UBS Group raised their price objective on shares of Corteva from $67.00 to $71.00 and gave the stock a “buy” rating in a report on Thursday, November 7th. Finally, Bank of America raised their price objective on shares of Corteva from $67.00 to $69.00 and gave the stock a “buy” rating in a report on Wednesday, November 20th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and fourteen have assigned a buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $65.06.
View Our Latest Stock Analysis on CTVA
Corteva Profile
Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.
Featured Stories
- Five stocks we like better than Corteva
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Survey Reveals: Which States Saw the Biggest Investment Gains in 2024?
- What is the S&P 500 and How It is Distinct from Other Indexes
- Amazon’s Healthcare Gamble: A New Era of Medical Disruption
- The Risks of Owning Bonds
- Semiconductor Giant Synopsys Slides 14% — Time to Take Notice
Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVA – Free Report).
Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.